Stereotactic ablative radiotherapy for oligometastatic prostate cancer

BACKGROUND: The present study assessed clinical outcomes of stereotactic body radiotherapy (SBRT) in oligometastatic prostate cancer patients. MATERIALS AND METHODS: Between 2017 and 2020, 37 lesions (12 osseous and 25 nodal targets) detected with conventional and/or functional imaging, were treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallizia, Elena, Ferrara, Eleonora, Beldì, Debora, Zannetti, Micol, Loi, Gianfranco, Franco, Pierfrancesco, Gennari, Alessandra, Krengli, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746650/
https://www.ncbi.nlm.nih.gov/pubmed/36523805
http://dx.doi.org/10.5603/RPOR.a2022.0088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746650/
https://www.ncbi.nlm.nih.gov/pubmed/36523805
http://dx.doi.org/10.5603/RPOR.a2022.0088

Ejemplares similares